Chicago Capital’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58.4M | Buy |
867,009
+129,384
| +18% | +$8.62M | 1.41% | 23 |
|
|
2026
Q1 | $46.3M | Buy |
737,625
+193,023
| +35% | +$13.4M | 1.25% | 27 |
|
|
2025
Q4 | $36.1M | Sell |
544,602
-344,884
| -39% | -$22.3M | 0.89% | 37 |
|
|
2025
Q3 | $59.9M | Buy |
889,486
+3,104
| +0.4% | +$246K | 1.47% | 22 |
|
|
2025
Q2 | $77.4M | Buy |
886,382
+850
| +0.1% | +$66.6K | 1.91% | 20 |
|
|
2025
Q1 | $60.5M | Buy |
885,532
+379,586
| +75% | +$31M | 1.71% | 24 |
|
|
2024
Q4 | $39.3M | Buy |
505,946
+22,167
| +5% | +$1.64M | 1.04% | 33 |
|
|
2024
Q3 | $32.4M | Sell |
483,779
-193,545
| -29% | -$15.9M | 0.9% | 38 |
|
|
2024
Q2 | $76.8M | Buy |
677,324
+1,842
| +0.3% | +$233K | 2.28% | 12 |
|
|
2024
Q1 | $93.7M | Sell |
675,482
-1,706
| -0.3% | -$214K | 2.86% | 7 |
|
|
2023
Q4 | $84M | Buy |
677,188
+43,161
| +7% | +$4.41M | 3.03% | 8 |
|
|
2023
Q3 | $59.2M | Buy |
634,027
+28,927
| +5% | +$3.26M | 2.77% | 12 |
|
|
2023
Q2 | $77.8M | Buy |
605,100
+22,256
| +4% | +$2.69M | 3.51% | 4 |
|
|
2023
Q1 | $67.7M | Sell |
582,844
-2,337
| -0.4% | -$262K | 3.37% | 6 |
|
|
2022
Q4 | $66.3M | Sell |
585,181
-6,864
| -1% | -$754K | 3.67% | 2 |
|
|
2022
Q3 | $47.7M | Sell |
592,045
-26,261
| -4% | -$2.22M | 2.76% | 10 |
|
|
2022
Q2 | $46.1M | Sell |
618,306
-1,438
| -0.2% | -$131K | 2.55% | 11 |
|
|
2022
Q1 | $79.3M | Buy |
619,744
+32,444
| +6% | +$3.55M | 3.41% | 4 |
|
|
2021
Q4 | $78.8M | Sell |
587,300
-13,008
| -2% | -$1.87M | 2.94% | 8 |
|
|
2021
Q3 | $82.1M | Sell |
600,308
-7,920
| -1% | -$999K | 3.11% | 5 |
|
|
2021
Q2 | $64.9M | Sell |
608,228
-9,144
| -1% | -$878K | 2.54% | 12 |
|
|
2021
Q1 | $55.5M | Buy |
617,372
+19,944
| +3% | +$1.87M | 2.34% | 15 |
|
|
2020
Q4 | $55.2M | Buy |
597,428
+36,108
| +6% | +$3.22M | 2.47% | 13 |
|
|
2020
Q3 | $57.8M | Sell |
561,320
-103,172
| -16% | -$10.8M | 2.97% | 5 |
|
|
2020
Q2 | $67.3M | Sell |
664,492
-38,644
| -5% | -$3.46M | 3.9% | 1 |
|
|
2020
Q1 | $47.3M | Sell |
703,136
-65,804
| -9% | -$4.09M | 3.82% | 2 |
|
|
2019
Q4 | $42M | Sell |
768,940
-13,356
| -2% | -$633K | 2.57% | 7 |
|
|
2019
Q3 | $29.2M | Buy |
782,296
+3,604
| +0.5% | +$140K | 1.95% | 19 |
|
|
2019
Q2 | $29.2M | Buy |
778,692
+9,428
| +1% | +$296K | 1.87% | 19 |
|
|
2019
Q1 | $22.9M | Sell |
769,264
-3,656
| -0.5% | -$128K | 1.56% | 30 |
|
|
2018
Q4 | $23.1M | Sell |
772,920
-2,624
| -0.3% | -$83.2K | 1.89% | 23 |
|
|
2018
Q3 | $27.7M | Sell |
775,544
-179,892
| -19% | -$5.58M | 1.92% | 26 |
|
|
2018
Q2 | $22.7M | Buy |
955,436
+330,584
| +53% | +$7.01M | 1.83% | 26 |
|
|
2018
Q1 | $11.6M | Buy |
+624,852
| New | +$9.24M | 1.55% | 30 |
|
Other funds holding DXCM
Chicago Capital's DXCM Position: Q2 2026 in Review
Chicago Capital increased its DexCom (DXCM) stake by 18% in Q2 2026, buying an estimated $8.62M and bringing the position to 867,009 shares worth $58.4M. The position accounts for 1.41% of the portfolio, ranked #23.
Chicago Capital first reported a position in DXCM in Q1 2018 and has held it in 34 quarters since. The position peaked at $93.7M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Chicago Capital held 867,009 shares of DexCom worth $58.4M as of Q2 2026.
- Chicago Capital bought 129,384 DexCom shares in Q2 2026, an estimated $8.62M.
- DexCom made up 1.41% of Chicago Capital's portfolio in Q2 2026, its #23 holding.
- Chicago Capital first reported a position in DexCom in Q1 2018 and has held it in 34 quarters since.
- Chicago Capital's DexCom position peaked at $93.7M in Q1 2024.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.